Big Pharma rears up to fight CA drug price bill; Vertex advances early-stage CF drugs;

@FierceBiotech: Wyss spins out pathogen-capturing tech into upstart biotech. Story | Follow @FierceBiotech

@JohnCFierce: CDK 4/6 inhibition (no. 2) With FDA 'breakthrough' in hand, Eli Lilly shoots for accelerated abemaciclib OK. Report | Follow @JohnCFierce

> Big Pharma is putting its financial weight behind an effort to defeat a California bill that would restrict drug pricing. More

> Vertex Pharmaceuticals ($VRTX) is planning to advance a pair of next-generation cystic fibrosis treatments into clinical development this fall, looking to test one in tandem with its recently approved combo therapy Orkambi. News

> Wall Street's biotech reticence has slowed the pace of industry IPOs. Story

Medical Device News

@FierceMedDev: ICYMI yesterday: GE Ventures reaffirms commitment to VC with med tech startup program. Article | Follow @FierceMedDev

@VarunSaxena2: #AdvaMed15: CMS has 30 people to evaluate 30,000 diagnostic tests, but more FDA oversight is likely. More | Follow @VarunSaxena2

@EmilyWFierce:  OKs expanded label for InSightec's noninvasive ultrasound fibroid device. News | Follow @EmilyWFierce

> Harvard's Wyss launches Opsonix, backed by Baxter in $8M to get sepsis device into clinic. More

> Study shows UV light-emitting robot reduces hospital-associated infections by 30%. Article

Pharma News

@FiercePharma: Cipla, Serum partner to provide vaccines in S. Africa. More | Follow @FiercePharma

@EricPFierce: Sanofi's Kansas City, MO plant back on the block as its August 2016 closing looms. Story | Follow @EricPFierce

@CarlyHFierce: It's a big day today. Image | Follow @CarlyHFierce

> Oncologists' pricing pushback mounts as docs snub costly me-too drugs. News

> Big Pharma teams up to defeat drug pricing proposal in California. More

Vaccines News

> FDA puts clinical hold on Advaxis' cervical cancer vaccine. More

> Allegheny General Hospital joins Sanofi's Cdiffense PhIII trial. Report

> Cipla, Serum partner to provide vaccines in S. Africa. Story

> Pfizer completes acquisition of two GSK meningitis vaccines. Item

> With PhII data, Genocea's herpes jab continues on blockbuster path, CEO says. Article

CRO News

> WuXi takes its genomics biz to Qatar with new hospital partnership. Report

> Evotec inks a $4.9M deal for oncology R&D. More

> PPD signs a pair of federal deals for battlefield health, flu readiness. Story

> INC bolsters its Phase I platform with new cardiac tech. Item

> Charles River signs a trio of deals in drug discovery. Article

Pharma Manufacturing News

> Cipla moves forward with deal for plant in Algeria. Item

> Investor buys Italian CDMO with plans to roll up others. Report

> Hospira manufacturing mess-up leads to PharMEDium recalls. Story

> Sanofi puts Allegra plant in U.S. back up for sale. Article

Pharma Asia News

> Japan's SymBio partners with Medicines Co. on pain reliever Ionsys. Item

> China gets its due with Nobel, but research problems still remain. Report

> China Biologic subsidiary inks deal to source raw plasma. More

> Singapore's TauRx completes $135M fundraising for PhIII Alzheimer's work. Article

> China's BeiGene snaps up Pfizer executive to run manufacturing ops. Story

Suggested Articles

The data, from two patients with severe blood disorders, are "promising” for what could be a one-and-done treatment, Cantor Fitzgerald analysts wrote.

The fund will back pharma companies as well as developers of medtech products and providers of outsourced services.

The money will fund work to develop polymers in multiple indications and an associated U.S. expansion.